Retour
Fourchette du Jour
45,71 €
47,17 €
Fourchette 52 Semaines
18,26 €
49,12 €
Volume
623 032
Moyenne 50J / 200J
44,22 €
/
37,72 €
Clôture Précédente
46,08 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 57,9 | 0,4 |
| P/B | 6,0 | 2,9 |
| ROE % | 11,7 | 3,7 |
| Net Margin % | 8,7 | 3,8 |
| Rev Growth 5Y % | 104,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 104,76% annually over 5 years — strong growth
ROE of 11,73% — decent returns on equity
Debt/Equity of 0,02 — conservative balance sheet
Generating 25,41M in free cash flow
P/E of 57,90 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 44,67%
Croissance
Revenue Growth (5Y)
104,76%
Revenue (1Y)60,09%
Earnings (1Y)N/A
FCF Growth (3Y)38,90%
Qualité
Return on Equity
11,73%
ROIC10,04%
Net Margin8,71%
Op. Margin11,40%
Sécurité
Debt / Equity
0,02
Current Ratio3,79
Interest Coverage0,00
Valorisation
P/E Ratio
57,90
P/B Ratio6,02
EV/EBITDA42,22
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60,09% | Revenue Growth (3Y) | 58,34% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | 104,68% |
| Revenue Growth (5Y) | 104,76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 677,56M | Net Income (TTM) | 59,01M |
| ROE | 11,73% | ROA | 7,73% |
| Gross Margin | 54,63% | Operating Margin | 11,40% |
| Net Margin | 8,71% | Free Cash Flow (TTM) | 25,41M |
| ROIC | 10,04% | FCF Growth (3Y) | 38,90% |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 3,79 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 57,90 | P/B Ratio | 6,02 |
| P/S Ratio | 5,04 | PEG Ratio | -0,22 |
| EV/EBITDA | 42,22 | Dividend Yield | 0,00% |
| Market Cap | 3,42B | Enterprise Value | 3,26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 677,56M | 423,24M | 270,26M | 220,18M | 38,54M |
| Net Income | 59,01M | -43,19M | 14,08M | 183,36M | -157,92M |
| EPS (Diluted) | 0,75 | -0,60 | 0,20 | 2,60 | -2,30 |
| Gross Profit | 370,15M | 362,33M | 213,74M | 197,29M | 29,44M |
| Operating Income | 77,22M | -45,62M | -25,20M | 9,77M | -156,64M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 763,63M | 580,55M | 526,32M | 459,67M | 232,80M |
| Total Liabilities | 196,03M | 142,12M | 87,48M | 63,52M | 47,76M |
| Shareholders' Equity | 567,61M | 438,44M | 438,84M | 396,15M | 185,04M |
| Total Debt | 9,50M | 9,86M | 12,26M | 5,92M | 6,05M |
| Cash & Equivalents | 165,60M | 183,58M | 107,95M | 122,72M | 122,47M |
| Current Assets | 527,18M | 331,80M | 276,30M | 243,06M | 196,45M |
| Current Liabilities | 139,18M | 100,62M | 63,67M | 47,07M | 44,82M |